arena pharmaceuticals inc
(ARNA:NASDAQ GS)
As of 4:30 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - arena pharmaceuticals inc (ARNA)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Phillip Schneider | 8 Relationships | Director and Chairman of Audit Committee | |
| Scott Bice | 15 Relationships | Independent Director, Member of Audit Committee and Member of Corporate Governance & Nominating Committee | |
| Christine White M.D. | 19 Relationships | Independent Director, Member of Compensation Committee and Member of Audit Committee |
Nominating Committee* - arena pharmaceuticals inc (ARNA)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Donald Belcher | 18 Relationships | Director and Chairman of Corporate Governance & Nominating Committee | Arena Pharmaceuticals, Inc. Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs 07/5/12 |
| Scott Bice | 15 Relationships | Independent Director, Member of Audit Committee and Member of Corporate Governance & Nominating Committee | Arena Pharmaceuticals, Inc. Announces Executive Changes 06/20/12 |
| Harry Hixson Jr., Ph.D. | 33 Relationships | Independent Director and Member of Corporate Governance & Nominating Committee | Robert E. Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer 08/12/11 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| ARNA:US | $7.99 USD | +0.03 |  |
| Company | Last | Change |
| Cell Therapeutics Inc | $1.32 USD | +0.10 |
| GlaxoSmithKline Consumer Healthcare Ltd | 4,789 INR | -1.15 |
| GlaxoSmithKline PLC | 1,742 GBp | +20.50 |
| Roche Holding AG | SFr.251.00 CHF | +4.00 |
| Vivus Inc | $13.16 USD | +0.18 |
| View Industry Companies | ||
Industry Analysis
ARNA
Industry Average
| Valuation | ARNA | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 62.3x |
|
| Price/Book | 21.6x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 54.8x |
|
Post a JobJobs
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
